e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Current status of cell-based therapies for respiratory virus infections: applicability to COVID-19
Maroun Khoury, Jimena Cuenca, Fernanda F. Cruz, Fernando E. Figueroa, Patricia R.M. Rocco, Daniel J. Weiss
Source:
Eur Respir J, 55 (6) 2000858; 10.1183/13993003.00858-2020
Journal Issue:
June
Disease area:
Respiratory critical care, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Maroun Khoury, Jimena Cuenca, Fernanda F. Cruz, Fernando E. Figueroa, Patricia R.M. Rocco, Daniel J. Weiss. Current status of cell-based therapies for respiratory virus infections: applicability to COVID-19. Eur Respir J, 55 (6) 2000858; 10.1183/13993003.00858-2020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Definition and history of sarcoidosis
Evidence of early abnormal airways’ inflammation in children with type 1 diabetes
Consistent effect of nintedanib on reducing FVC decline across interstitial lung diseases (ILDs)
Related content which might interest you:
From the bedside: upcoming new clinical strategies: novel strategies to combat respiratory viral infections
Source: International Congress 2017 – Scientific year in review
Year: 2017
Are antimicrobials still the future of respiratory infection therapy?
Source: Virtual Congress 2021 – Emerging data for the management of respiratory tract infections
Year: 2021
Dynamics of IFN-ß responses during respiratory viral infection: insights for therapeutic strategies
Source: International Congress 2019 – Mechanisms underlying respiratory infection
Year: 2019
Update on management of new emerging acute respiratory viral infectious diseases
Source: International Congress 2018 – Chinese Programme 2018: Part I
Year: 2018
The role of virus infections in asthma: immune responses and future possibilities
Source: Annual Congress 2007 - PG24 - GRACE full-day course. From cough to asthma: the role of infection
Year: 2007
New treatments for RSV and other viruses, including update on vaccines
Source: ERS Courses: Paediatric respiratory infections
Year: 2019
The efficacy of antiviral therapy of acute respiratory infections in paediatric practice
Source: International Congress 2017 – New insights into paediatric respiratory infections
Year: 2017
Emerging respiratory virus infections threaten pulmonary health
Source: Virtual Congress 2021 – Viral infections trigger chronic lung damage and disease
Year: 2021
The immunology of virus infection in asthma
Source: Eur Respir J 2001; 18: 1013-1025
Year: 2001
Interactions between bacterial and viral infections during COPD exacerbations: implications for prevention strategies
Source: International Congress 2019 – Scientific Year in review
Year: 2019
Economic aspects of enhanced testing strategies for respiratory diseases
Source: Value-Dx event 2021: Community-acquired respiratory tract infections: where do we stand in 2021, ECCMID 2021
Year: 2021
Simultaneous use of probiotics and vaccines for prevention of pneumonia and respiratory infections in servicemen
Source: Eur Respir J 2006; 28: Suppl. 50, 154s
Year: 2006
Prevention and treatment of viral infections: CMV and other community respiratory viruses
Source: ERS Course 2016
Year: 2016
Potential impact and relevance of diagnostics in the management of respiratory tract infections: from COVID to hospital-acquired pneumonia
Source: Virtual Congress 2021 – Emerging data for the management of respiratory tract infections
Year: 2021
Applying new respiratory function technologies to the elderly and the potential of future lung regeneration
Source: Virtual Congress 2020 – Lung health and respiratory function at all ages
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept